More than one quarter of patients with haematologic malignancies who contract a COVID-19 infection die, according to global data presented at the ASH 2020 Annual Meeting. “Haematologic diseases often induce underlying immune dysregulation or dysfunction,” said Dr William Wood, of the University of North Carolina, who presented the new results. “Patients with haematologic malignancies are ...
Haematologic malignancies associated with higher COVID-19 mortality rates
By Dave Levitan
7 Dec 2020